Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer

BACKGROUND: Neoadjuvant treatment plays a crucial role in the therapy of advanced esophageal cancer. However, response to radiochemotherapy varies widely. Proton pump inhibitors (PPIs) have been demonstrated to impact on chemotherapy in a variety of other cancers. We analyzed the impact of PPI treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindner, Kirsten, Borchardt, Christiane, Schöpp, Maren, Bürgers, Anja, Stock, Christian, Hussey, Damian J, Haier, Jörg, Hummel, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431491/
https://www.ncbi.nlm.nih.gov/pubmed/25175076
http://dx.doi.org/10.1186/s13046-014-0073-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431491/
https://www.ncbi.nlm.nih.gov/pubmed/25175076
http://dx.doi.org/10.1186/s13046-014-0073-x

Ejemplares similares